CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
about
Comparative inter-strain sequence analysis of the putative regulatory region of murine psychostimulant-regulated gene GNB1 (G protein beta 1 subunit gene).Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples.Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity.Molecular basis of lithium action: integration of lithium-responsive signaling and gene expression networks.Abnormalities of cAMP signaling in affective disorders: implication for pathophysiology and treatment.The neurobiology of bipolar disorder: focus on signal transduction pathways and the regulation of gene expression.Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers.Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients.Mood stabilizer psychopharmacologyCarbamazepine extended-release capsules: a new treatment option for bipolar I disorder.Heterotrimeric g proteins: insights into the neurobiology of mood disorders.Alterations in the levels of heterotrimeric G protein subunits induced by psychostimulants, opiates, barbiturates, and ethanol: Implications for drug dependence, tolerance, and withdrawal.Modulation of stress by imidazoline binding sites: implications for psychiatric disorders.SNPs in genes encoding G proteins in pharmacogenetics.Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder.[3H]PtdIns hydrolysis in postmortem human brain membranes is mediated by the G-proteins Gq/11 and phospholipase C-beta.Fluorometric assays of phospholipase A2 activity with three different substrates in biological samples of patients with schizophrenia.Future therapies for schizophrenia
P2860
Q31027805-49AE75C7-FC1A-475F-A670-E2D6CF0CA9B7Q33784255-381F01E7-7CA0-4701-A0B1-4EE22BE625FEQ33844558-C53215FE-7298-4E48-BAC3-1CF390808816Q34180376-8292D14F-2932-468A-8867-1F9CB0C2D35CQ34186921-41EB913C-6FD2-43EF-B2B0-2BE729C506BDQ34582990-DFA31903-C1EA-4D2E-81F3-983B7C9C44BFQ35770186-771C8927-992C-4F34-A63A-A204AAC1C7A0Q35793350-39803E3C-586D-474D-93D4-6029CD2EB404Q36031634-66D4CBDE-7EB6-4E7B-BB45-2940FF822067Q36257188-F88DB021-FE79-480A-8EA8-756F1745C7C2Q36726610-7F175EEA-9A8B-4C03-9EF9-212545F042D8Q37102172-986ADE77-D17E-4082-BED1-E79AFC54F947Q37324414-E013C6CC-D7E3-46A8-B74C-524B661D25BDQ37880876-16CC9656-5F74-4C75-A82F-6575C30F1B04Q42508381-348D3787-533F-416E-84B7-B3155994AF9CQ42830775-69355F47-6645-4A07-8D9A-0FCAB3EC0456Q47664457-78B15906-771B-4EEF-8552-C0780768E2ABQ57403453-34567B97-FBEB-48E0-8B97-D982B3C8702C
P2860
CNS signal transduction in the pathophysiology and pharmacotherapy of affective disorders and schizophrenia.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
CNS signal transduction in the ...... e disorders and schizophrenia.
@en
type
label
CNS signal transduction in the ...... e disorders and schizophrenia.
@en
prefLabel
CNS signal transduction in the ...... e disorders and schizophrenia.
@en
P2093
P2860
P356
P1433
P1476
CNS signal transduction in the ...... e disorders and schizophrenia.
@en
P2093
P2860
P304
P356
10.1002/SYN.890130311
P577
1993-03-01T00:00:00Z